SCHEMBL6723333

SCHEMBL6723333

O=C(O)[C@@H]1[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)[C@@H]1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.59
GBA1 P04062 2/20 0.47
KDM4E B2RXH2 1/20 0.42
GMNN O75496 1/20 0.42
LMNA P02545 1/20 0.42
PMP22 Q01453 1/20 0.42
TFPI2 P48307 1/20 0.42
TP53 P04637 1/20 0.42
NFKB1 P19838 1/20 0.42
THPO P40225 1/20 0.42
PPP5C P53041 2/20 0.41
SUCNR1 Q9BXA5 1/20 0.38
GRM2 Q14416 2/20 0.36
GRM3 Q14832 2/20 0.36
POLB P06746 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
PPM1B O75688 1/20 0.31
PTPN1 P18031 1/20 0.31
PPP1CC P36873 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723339 1.00 TSHR (0.59) TSHRGBA1KDM4EGMNNLMNA
SCHEMBL15796345 0.84 TSHR (0.68) TSHRGBA1KDM4EGMNNLMNA
SCHEMBL1665130 0.81 TSHR (0.65) TSHRKDM4EGMNNLMNAPMP22
Hydrochloric Acid SCHEMBL9445206 0.81 TSHR (0.65) TSHRKDM4EGMNNLMNAPMP22
SCHEMBL7827217 0.81 TSHR (0.65) TSHRKDM4EGMNNLMNAPMP22
SCHEMBL14972599 0.77 TSHR (0.59) TSHRKDM4EGMNNLMNAPMP22
SCHEMBL6796708 0.75 TSHR (0.41) TSHRPPP5CPPM1BPTPN1PPP1CC
SCHEMBL6796704 0.75 TSHR (0.41) TSHRPPP5CPPM1BPTPN1PPP1CC
SCHEMBL1663988 0.72 TSHR (0.48) TSHRKDM4EGMNNLMNAPMP22
SCHEMBL1663194 0.72 TFPI2 (0.50) TSHRKDM4EGMNNLMNAPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242897-A1 Universal support media for synthesis of oligomeric compounds ISIS PHARMACEUTICALS, INC. 2004-12-02 US disclosed
US-20040152905-A1 Universal building blocks and support media for synthesis of oligonucleotides and their analogs ISIS PHARMACEUTICALS, INC. 2004-08-05 US disclosed
US-6653468-B1 Bicyclic heptane derivatives linked to controlled pore glass or copolymers of polystyrene; can be cleaved and used for subsequent reactions ISIS PHARMACEUTICALS, INC. 2003-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152905-A1 Universal building blocks and support media for synthesis of oligonucleotides and their analogs POLM, POLRMT, POLB TSHR 3397/4885GBA1 3140/4885KDM4E 4608/4885
US-20040242897-A1 Universal support media for synthesis of oligomeric compounds NEFM, POLRMT, POLM TSHR 4495/4885GBA1 3292/4885KDM4E 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.